3Qian QJ,Jonathan S,Che XY,et al.Gene-viral vectors:a promising way to target tumor cells and express anticancer genes simultaneously.Chin Med J,2002,115:1213-1217.
4LaBarre DD,Lowy RJ.Improvements in methods for calculating virus titer estimates from TCID50 and plaque assays.J Virol Methods,2001,96:107-126.
5Smith ER,Chiocca EA.Oncolytic viruses as novel anticancer agents:turning one scourage against another.Exp Opin Invest Drugs,2000,9:311-327.
6Ring CJ.Cytolytic virus as potential anti-cancer agents.J Gen Vivol,2002,83:491-520.
7Hallenbeck PL,Chang YN,Hay C,et al.A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma.Hum Gene Ther,1998,10:1721-1733.
8Tahara H,Nakanishi T,Ritamato M,et al.Telomerase activity in human liver tissues:comparison between chronic liver disease and hepatocellular carcinomas.Cancer Research,1995,55:2734-2736.
9Desaknai S, Lumniczky K, Esik O, et al. Local tumour irradiation enhances the anti-tumour effect of a double-suicide gene therapy system in a murine glioma model.J Gene Med, 2003,5:377-385.
10Shand N, Weber F, Mariani L, et al. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group.Hum Gene
3Moon IK, Jarstfer MB. The human telomere and its relationship to hu- man disease, therapy, and tissue engineering [ J ]. Front Biosci, 2007, 12(1) : 4595 -4620.
4Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of hu- man telomerase activity with immortal ceils and cancer [ J ]. Science, 1999, 266(5193) : 2011 -2015.
5Fakhoury J, Nimmo GA, Autexier C. Harnessing telomerase in cancer therapeutics [ J]. Anticancer Agents Med Chem, 2007, 7 (4) : 475 - 483.
6Counter CM, Meyerson M, Eaton EN, et al. Telornerase activity is re- stored in human cells by ectopic expression of hTERT (hEST2) , the catalytic subunit of telomerase [ J]. Oncogene, 1998, 16(9) : 1217 - 1222.
7Fabriciuse EM, Kruse - Boitschenko U, Khoury R, et al. Immunohis- tochemical determination of the appropriate anti - hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues [ J]. Int J Oncol, 2009, 34(5): 1257- 1279.
8Wooten - Blanks LG, Song P, Senkal CE, et al. Mechanisms of ce- ramide- mediated repression of the human telomerase reverse tran- scriptase promoter via deacetylation of Sp3 by histone deacetylase 1 [J]. FASEB J,2007, 21(12) :3386 -3397.
9Takakura M, Kyo S, Kanaya T, et al. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in im- mortalized and cancer cells [J]. Cancer Res, 1999, 59(3) : 551 - 557.
10Gu J, Kagawa S, Takakura M, et al. Tumor- specific transgene ex- pression from the human telomerase reverse transcriptase promoter ena- bles targeting of the therapeutic effects of the Bax gene to cancers [ J ]. Cancer Res, 2000, 60(19) : 5359 -5364.
